Genmab
GMAB
#1371
Rank
S$17.83 B
Marketcap
$27.01
Share price
-0.79%
Change (1 day)
-34.39%
Change (1 year)

Genmab (GMAB) - Cash on Hand

Cash on Hand as of September 2024 : S$3.50 Billion

According to Genmab's latest financial reports the company has S$3.50 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Genmab - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$5.50 B27.69%
2022-12-31S$4.30 B8.28%
2021-12-31S$3.98 B13.2%
2020-12-31S$3.51 B58.55%
2019-12-31S$2.21 B73.52%
2018-12-31S$1.27 B9.3%
2017-12-31S$1.16 B45.49%
2016-12-31S$0.80 B10.99%
2015-12-31S$0.72 B26.12%
2014-12-31S$0.57 B57.21%
2013-12-31S$0.36 B12.01%
2012-12-31S$0.32 B31.32%
2011-12-31S$0.24 B-34.51%
2010-12-31S$0.37 B9.73%
2009-12-31S$0.34 B-26.98%
2008-12-31S$0.47 B1175.3%
2007-12-31S$37.1 M-92.09%
2006-12-31S$0.46 B41.94%
2005-12-31S$0.33 B165.08%
2004-12-31S$0.12 B40.37%
2003-12-31S$88.76 M42.77%
2002-12-31S$62.17 M